CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients

Circulation

Volumn 109, Issue 22, 2004, Pages 2744-2748

  Gerli, Roberto ^a   Schillaci, Giuseppe ^a   Giordano, Andrea ^a   Bocci, Elena Bartoloni ^a   Bistoni, Onelia ^a   Vaudo, Gaetano ^a   Marchesi, Simona ^a   Pirro, Matteo ^a   Ragni, Federica ^a   Shoenfeld, Yehuda ^b   Mannarino, Elmo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Arthritis, rheumatoid; Cells; Endothelium; Vasodilation

Indexed keywords

CD28 ANTIGEN; CD4 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ATHEROMA; ATHEROSCLEROSIS; BRACHIAL ARTERY; CAROTID ARTERY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INTIMA; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; THICKNESS; TUNICA MEDIA; VASODILATATION;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ARTERIOSCLEROSIS; ARTHRITIS, RHEUMATOID; CAROTID ARTERIES; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION;

EID: 2942547418     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000131450.66017.B3     Document Type: Article

References (46)

1. Van Doornum S, Mc Coll G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 2002;46:862-873.
2. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003; 107:1303-1307.
3. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
4. Pasceri V, Yeh ETH. A tale of two diseases: atherosclerosis and rheumatoid arthritis. Circulation. 1999;100:2124-2126.
5. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest. 1996;97:2027-2037.
6. Martens PB, Goronzy JJ, Schaid D, et al. Expansion of unusual CD4+ T cells in severe rheumatoid arthritis. Arthritis Rheum. 1997;40:1106-1114.
7. Liuzzo G, Kopecky SL, Frye RL, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135-2139.
8. Liuzzo G, Goronzy JJ, Yang H, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883-2888.
9. Namekawa T, Wagner UG, Goronzy JJ, et al. Functional subsets of CD4 T cells in rheumatoid synovitis. Arthritis Rheum. 1998;41:2108-2116.
10. Warrington KJ, Takemura S, Goronzy JJ, et al. CD4+, CD28- T cells in rheumatoid arthritis patients combine features of the innate and adaptive immune systems. Arthritis Rheum. 2001;44:13-20.
11. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315-324.
12. Prevoo ML, van't Hof MA, Kuper HH, et al. Modified disease activity scores that include twenty-eight-joint counts: development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44-48.
13. Gerli R, Paolucci C, Gresele P, et al. Salicylates inhibit adhesion and transmigration of T lymphocytes by preventing integrin activation induced by contact with endothelial cells. Blood. 1998;92:2389-2397.
14. Marchesi S, Lupattelli G, Schillaci G, et al. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis. 2000;153:397-402.
15. Vaudo G, Schillaci G, Evangelista F, et al. Arterial wall thickening at different sites and its association with left ventricular hypertrophy in newly diagnosed essential hypertension. Am J Hypertens. 2000;13:324-331.
16. Kumeda Y, Inaba M, Goto M, et al. Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum. 2002;46:1489-1497.
17. Park Y-B, Ahn C-W, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum. 2002; 46:1714-1719.
18. Bergholm R, Leirisalo-Repo M, Vehkavaara S, et al. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol. 2002;22:1637-1641.
19. Vaudo G, Marchesi S, Gerli R, et al. Endothelial dysfunction in young rheumatoid arthritis patients with low disease activity. Ann Rheum Dis. 2004;63:31-35.
20. Gerli R, Pitzalis C, Lunardi C. The role of T cell cytokines in modulating joint inflammation in rheumatoid arthritis. Isr Med Assoc J. 2002;4:949-952.
21. Morita Y, Yamamura M, Nishida K, et al. Expression of interleukin 12 in synovial tissue from patients with rheumatoid arthritis. Arthritis Rheum. 1998;41:306-314.
22. Warrington KJ, Vallejo AN, Weyand CM, et al. CD28 loss in senescent CD4+ T cells: reversal by interleukin-12 stimulation. Blood. 2003;101:3543-3549.
23. Bryl E, Vallejo AN, Weyand CM, et al. Down regulation of CD28 expression by TNFα. J Immunol. 2001;167:3231-3238.
24. Posnett DN, Sinha R, Kabak S, et al. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammopathy." J Exp Med. 1994;179:609-618.
25. Effros RB, Boucher N, Porter V, et al. Decline in CD28+ T cells in centenarians and in long term T cells cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp Gerontol. 1994;29:601-609.
26. Gerli R, Monti D, Bistoni O, et al. Chemokines, sTNF-Rs, and sCD30 serum levels in healthy aged people and centenarians. Mech Ageing Dev. 2000;121:37-46.
27. Komocsi A, Lamprecht P, Csernok E, et al. Peripheral blood and granuloma CD4+CD28- T cells are a major source of interferon-γ and TNF-α in Wegener's granulomatosis. Am J Pathol. 2002;160:1717-1724.
28. Markovic-Plese S, Cortese I, Wandinger KP, et al. CD4+CD28-costimulation-independent T cells in multiple sclerosis. J Clin Invest. 2001; 108:1185-1194.
29. Park W, Weyand CM, Schmitd D, et al. Co-stimulatory pathways controlling activation and peripheral tolerance of human CD4+CD28- T cells. Eur J Immunol. 1997;27:1082-1090.
30. Sherer Y, Shoenfeld Y. Immunomodulation for treatment and prevention of atherosclerosis. Autoimmun Rev. 2002;1:21-27.
31. Gerli R, Lunardi C, Vinante F, et al. Role of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases. Trends Immunol. 2001;22:72-77.
32. Gerli R, Lunardi C, Pitzalis C. Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis. Rheumatology. 2002;41:1341-1345.
33. Mutru O, Laakso M, Isomaki H, et al. Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology. 1989;76:71-77.
34. Myllykangas-Luosujarvi R, Aho K, Kautianen H, et al. Cardiovascular mortality in women with rheumatoid arthritis. J Rheumatol. 1995;22:1065-1067.
35. Wallberg-Jonsson S, Ohman ML, Rantapaa-Dahlqvist S. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in northern Sweden. J Rheumatol. 1997;24:445-451.
36. del Rincon I, Williams K, Stem MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-2745.
37. Bacon PA, Raza K, Banks MJ, et al. The role of endothelial cell dysfunction in the cardiovascular mortality of rheumatoid arthritis. Int Rev Immunol. 2002;21:1-17.
38. Goodson N. Coronary artery disease and rheumatoid arthritis. Curr Opin Rheumatol. 2002;14:115-120.
39. Taylor PC, Williams RO, Maini RN. Immunotherapy for rheumatoid arthritis. Curr Opin Immunol. 2001;13:611-616.
40. Criscione LG, St Clair EW. Tumor necrosis factor-α antagonists for the treatment of rheumatic diseases. Curr Opin Rheumatol. 2002;14:204-211.
41. Calabrese LH. Molecular differences in anticytokine therapies. Clin Exp Rheumatol. 2003;21:241-248.
42. Fichtlscherer S, Rössig L, Breuer S, et al. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure. Circulation. 2001;104:3023-3025.
43. Hürlimann D, Forster A, Noll G, et al. Anti-tumor necrosis factor-α treatment improves endothelial function in patients with rheumatoid arthritis. Circulation. 2002;106:2184-2187.
44. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101:1899-1906.
45. Perticone F, Ceravolo R, Pujia A, et al. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001;104:191-196.
46. Verma S, Anderson TJ. Fundamentals of endothelial function for the clinical cardiologist. Circulation. 2002;105:546-549.